1
|
Wu Q, Lv J, Xie F, Li S. Quantification of oxaliplatin- and ioversol-related compounds in pharmaceutical formulations using novel HPLC-ICP-MS methods. J Pharm Biomed Anal 2024; 242:116026. [PMID: 38367519 DOI: 10.1016/j.jpba.2024.116026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2023] [Revised: 02/04/2024] [Accepted: 02/08/2024] [Indexed: 02/19/2024]
Abstract
PURPOSE Accurate quantifying of drug-related compounds in medicines is vital for safety. Commonly used structure-dependent methods rely on analytical standards. High-performance liquid chromatography coupled with inductively coupled plasma-mass spectrometry (HPLC-ICP-MS) offers a promising solution, being structure-independent and not requiring standards. In this study, we aim to develop HPLC-ICP-MS methods for the determination of related compounds in oxaliplatin and ioversol injections. RESULTS The target analytes were eluted on an XSelect HSS T3 column (2.1 ×50 mm, 5 µm). Specifically, oxaliplatin injection was eluted isocracially for 3.5 min, and ioversol injection was eluted gradient with a total chromatographic run time of 12 min. The measurements to determine dihydroxy oxaliplatin-Pt(IV) and two related compounds of ioversol were performed by monitoring at m/z for 195Pt and 127I, respectively. The calibration curves were established over the range of 0.05-1 μM for Pt and 0.3-15 μM for I with the correlation coefficients greater than 0.999. The limits of quantification were 0.004 μM for dihydroxy oxaliplatin-Pt(IV), 0.022 μM for ioversol related compound A and 0.026 μM for ioversol related compound B. The accuracy (recovery between 93-105%) and precision (repeatability ≤ 6.1% RSD) were fit-for-purpose for dihydroxy oxaliplatin-Pt(IV), and the accuracy (recovery between 95-107%) and precision (repeatability ≤ 3.9% RSD) were also fit-for-purpose for both ioversol related compound A and ioversol related compound B. CONCLUSION The quantitation accuracy of HPLC-ICP-MS closely matched that of the standard HPLC-UV approach. HPLC-ICP-MS can be used as a complementary analytical technique for quantitative determination of drug-related compounds.
Collapse
Affiliation(s)
- Qiping Wu
- Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China
| | - Jianmei Lv
- Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China
| | - Feifan Xie
- Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China
| | - Sanwang Li
- Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha 410011, China; Institute of Clinical Pharmacy, Central South University, Changsha 410011, China.
| |
Collapse
|
2
|
Hasanah AN, Susanti I. Molecularly Imprinted Polymers for Pharmaceutical Impurities: Design and Synthesis Methods. Polymers (Basel) 2023; 15:3401. [PMID: 37631457 PMCID: PMC10457877 DOI: 10.3390/polym15163401] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2023] [Revised: 08/03/2023] [Accepted: 08/05/2023] [Indexed: 08/27/2023] Open
Abstract
The safety of a medicinal product is determined by its pharmacological and toxicological profile, which depends not only on the active substance's toxicological properties, but also on the impurities it contains. Because impurities are a problem that must be considered to ensure the safety of a drug product, many studies have been conducted regarding the separation or purification of active pharmaceutical ingredients (APIs) and the determination of impurities in APIs and drug products. Several studies have applied molecularly imprinted polymers (MIPs) to separate impurities in active ingredients and as adsorbents in the sample preparation process. This review presents the design of MIPs and the methods used to synthesise MIPs to separate impurities in APIs and drug product samples, the application of MIPs to separate impurities, and a view of future studies involving MIPs to remove impurities from pharmaceutical products. Based on a comparison of the bulk and surface-imprinting polymerisation methods, the MIPs produced by the surface-imprinting polymerisation method have a higher adsorption capacity and faster adsorption kinetics than the MIPs produced by the bulk polymerisation method. However, the application of MIPs in the analysis of APIs and drug products are currently only related to organic compounds. Considering the advantages of MIPs to separate impurities, MIPs for other impurities still need to be developed, including multi-template MIPs for simultaneous separation of multiple impurities.
Collapse
Affiliation(s)
- Aliya Nur Hasanah
- Pharmaceutical Analysis and Medicinal Chemistry Department, Faculty of Pharmacy, Universitas Padjadjaran, Jalan Raya Bandung Sumedang KM 21 Jatinangor, Bandung 45363, Indonesia;
- Drug Development Study Center, Faculty of Pharmacy, Universitas Padjadjaran, Jalan Raya Bandung Sumedang KM 21, Sumedang 45363, Indonesia
| | - Ike Susanti
- Pharmaceutical Analysis and Medicinal Chemistry Department, Faculty of Pharmacy, Universitas Padjadjaran, Jalan Raya Bandung Sumedang KM 21 Jatinangor, Bandung 45363, Indonesia;
| |
Collapse
|
3
|
Zhou Y, Lv X, Chen L, Zhang H, Zhu L, Lu Y, Chen X. Identification of Process-Related Impurities and Corresponding Control Strategy in Biocatalytic Production of 2- O-α-d-Glucopyranosyl-l-ascorbic Acid Using Sucrose Phosphorylase. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2022; 70:5066-5076. [PMID: 35412325 DOI: 10.1021/acs.jafc.2c00881] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
2-O-α-d-Glucopyranosyl-l-ascorbic acid (AA-2G) is an ideal substitute for l-ascorbic acid because of its remarkable stability and improved biological activity, which can be easily applied in cosmetic, food, and medicine fields. However, impurity identification and control are significant procedures during the manufacturing of AA-2G. This study assessed a manufacturing routine of AA-2G synthesized by sucrose phosphorylase (SPase). First, three unknown process-related impurities were observed, which were further identified as 3-O-α-d-glucopyranosyl- l-ascorbic acid (impurity I), 2-O-α-d-glucopyranosyl-l-dehydroascorbic acid (impurity II), and 13-O-α-d-glucopyranosyl-2-O-α-d-glucopyranosyl-l-ascorbic acid (impurity III), respectively. Second, a comprehensive formation pathway of impurities was elucidated, and specific strategies corresponding to controlling each impurity were also proposed. Specifically, the content of impurity I can be reduced by 50% by fine tuning reaction conditions. The impurity II-free purification process was also achieved by applying a low concentration of alkali. Finally, a semi-rational design was introduced, and a single mutant L343F was obtained by site-directed mutagenesis, which reduced impurities I and III by 63.9 and 100%, respectively, without affecting the transglycosylation activity. It is expected that the reported impurity identification and control strategies during the AA-2G production will facilitate its industrial production.
Collapse
Affiliation(s)
- Yaoyao Zhou
- Institute of Fermentation Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
| | - Xuhao Lv
- Institute of Fermentation Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
| | - Luyi Chen
- Institute of Fermentation Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
| | - Hui Zhang
- Institute of Fermentation Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
| | - Linjiang Zhu
- Institute of Fermentation Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
| | - Yuele Lu
- Institute of Fermentation Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
| | - Xiaolong Chen
- Institute of Fermentation Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, People's Republic of China
| |
Collapse
|
4
|
Lorrane Alves da Silva T, Ferreira RGL, Lustosa IA, Kogawa AC. An Overview of Analytical Methods for the Quantification of Marbofloxacin in Pharmaceutical, Biological and Food Matrices. J AOAC Int 2021; 105:456-462. [PMID: 34718603 DOI: 10.1093/jaoacint/qsab143] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2021] [Revised: 09/23/2021] [Accepted: 10/19/2021] [Indexed: 11/13/2022]
Abstract
BACKGROUND Marbofloxacin (MAR), a second-generation fluoroquinolone, is used in veterinary medicine in the form of tablets. It has a broad spectrum of action, low toxicity, and limited development of bacterial resistance. The analytical methods available in the literature become more important since MAR in tablets does not have a monograph in official compendiums. OBJECTIVE Thus, the purpose of this review is to display them according to the analyzed matrix and place them according to the conditions used in the scope of green analytical chemistry, in addition to discussing possible gaps and opportunities for the development of new methods. RESULTS MAR, being an antimicrobial, presents both physical-chemical (93%) and microbiological (7%) methods in the literature. Among the methods found, 53% are for analysis of food matrices using preferably HPLC and TLC-MS. 27% are for analysis of biological matrices and 20% are for analysis of pharmaceutical matrices, and in both HPLC is preferably used. CONCLUSIONS Therefore, there is still a gap in the literature in relation to other options of analytical methods for the analysis of MAR, which are faster, such as microbiological turbidimetry, sustainable, such as miniaturized methods, and ecologically correct, such as those that do not usetoxic organic solvents. HIGHLIGHTS A review of the status of analytical methods available in the literature for assessing the quality of MAR and MAR-based products were exhibited and discussed, as well as new opportunities for analysis according to green analytical chemistry.
Collapse
Affiliation(s)
| | | | - Isadora Alves Lustosa
- Laboratório de Controle de Qualidade, Faculdade de Farmácia, Universidade Federal de Goiás-UFG, Goiânia, Goiás, Brazil
| | - Ana Carolina Kogawa
- Laboratório de Controle de Qualidade, Faculdade de Farmácia, Universidade Federal de Goiás-UFG, Goiânia, Goiás, Brazil
| |
Collapse
|
5
|
Rocha LP, Cabral LM, Pinto EC, de Sousa VP. Ezetimibe: A Review of Analytical Methods for the Drug Substance, Pharmaceutical Formulations and Biological Matrices. Crit Rev Anal Chem 2020; 52:1078-1093. [PMID: 33347374 DOI: 10.1080/10408347.2020.1857222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Ezetimibe (EZM) is a selective inhibitor of the sterol transporter Niemann-Pick C1-Like 1 in the small intestine used as an adjunctive therapy to lower cholesterol levels in cases of hyperlipidemia. The goal of this work was to summarize the main physical-chemical, pharmacological and pharmacokinetic characteristics of EZM, as well as to describe the main analytical methodologies for the quantification of the drug. Methods described in the United States Pharmacopeia for EZM raw material and tablets were also presented. The drug has a large number of process-related impurities and degradation products and needs strict quality control of its impurities. Specific chiral methods for the evaluation of its chiral impurities are also a need for EZM. The main advantages and disadvantages of the compiled analytical methods were presented, as well as the limits of detection and quantitation. The fastest and most efficient methods were highlighted. Most methods for analyzing EZM used C8 or C18 stationary phases in gradient mode with binary mobile phases containing acetonitrile and an acidic buffer solution with ultraviolet detection. For analysis of EZM in biological matrices, liquid chromatography-tandem mass spectrometry is generally employed using electron spray ionization in negative ionization mode using multiple reaction monitoring. Different methods in the literature evaluate a large number of impurities for EZM, however new stability-indicating high-performance liquid chromatography methods for the drug are still needed.
Collapse
Affiliation(s)
- Letícia Pereira Rocha
- Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Lucio Mendes Cabral
- Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Eduardo Costa Pinto
- Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Valeria Pereira de Sousa
- Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| |
Collapse
|
6
|
Arar S, Al-Qudah E, Alzweiri M, Sweidan K. New forced degradation products of vildagliptin: Identification and structural elucidation using LC-MS, with proposed formation mechanisms. J LIQ CHROMATOGR R T 2020. [DOI: 10.1080/10826076.2020.1779084] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- Sharif Arar
- Department of Chemistry, School of Science, The University of Jordan, Amman, Jordan
| | - Enas Al-Qudah
- Department of Chemistry, School of Science, The University of Jordan, Amman, Jordan
| | - Muhammad Alzweiri
- Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman, Jordan
| | - Kamal Sweidan
- Department of Chemistry, School of Science, The University of Jordan, Amman, Jordan
| |
Collapse
|
7
|
Salunkhe MN, Gite SD, Kachave RN. Recent trends in impurity profiling and forced degradation of antihypertensive drugs. J LIQ CHROMATOGR R T 2017. [DOI: 10.1080/10826076.2017.1373670] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Megha N. Salunkhe
- Department of Quality Assurance Technique, Amrutvahini College of Pharmacy, Ahmednagar, Maharashtra, India
| | - Snehal D. Gite
- Department of Quality Assurance Technique, Amrutvahini College of Pharmacy, Ahmednagar, Maharashtra, India
| | - Ramanlal N. Kachave
- Department of Pharmaceutical Analysis, Amrutvahini College of Pharmacy, Ahmednagar, Maharashtra, India
| |
Collapse
|